Stirred culture of peripheral and cord blood hematopoietic cells offers advantages over traditional static systems for clinically relevant applications
- 5 September 1998
- journal article
- research article
- Published by Wiley in Biotechnology & Bioengineering
- Vol. 59 (5) , 534-543
- https://doi.org/10.1002/(sici)1097-0290(19980905)59:5<534::aid-bit2>3.0.co;2-b
Abstract
The ability to culture hematopoietic cells in readily characterizable and scalable stirred systems, combined with the capability to utilize serum‐free medium, will aid the development of clinically attractive bioreactor systems for transplantation therapies. We thus examined the proliferation and differentiation characteristics of peripheral blood (PB) mononuclear cells (MNC), cord blood (CB) MNC, and PB CD34+ cells in spinner flasks and (control) T‐flask cultures in both serum‐containing and serum‐free media. Hematopoietic cultures initiated from all sources examined (PB MNC, CB MNC, and PB CD34+ cells) grew well in spinner vessels with either serum‐containing or serum‐free medium. Culture proliferation in spinner flasks was dependent on both agitator design and RPM as well as on the establishment of critical inoculum densities (ID) in both serum‐containing (2 × 105 MNC/mL) and serum‐free (3 × 105 MNC/mL) media. Spinner flask culture of PB MNC in serum‐containing medium provided superior expansion of total cells and colony‐forming cells (CFC) at high ID (1.2 × 106 cells/mL) as compared to T‐flask controls. Serum‐free spinner culture was comparable, if not superior, to that observed in serum‐containing medium. This is the first report of stirred culture of PB or CB MNC, as well as the first report of stirred CD34+ cell culture. Additionally, this is the first account of serum‐free stirred culture of hematopoietic cells from any source. © 1998 John Wiley & Sons, Inc. Biotechnol Bioeng 59: 534–543, 1998.Keywords
This publication has 26 references indexed in Scilit:
- Culture materials affectex vivo expansion of hematopoietic progenitor cellsJournal of Biomedical Materials Research, 1997
- Real-time method for determining the colony-forming cell content of human hematopoietic cell culturesBiotechnology & Bioengineering, 1997
- Transforming growth factor beta (TGF-beta), a potent inhibitor of erythropoiesis: neutralizing TGF-beta antibodies show erythropoietin as a potent stimulator of murine burst-forming unit erythroid colony formation in the absence of a burst-promoting activityBlood, 1995
- An update on peripheral blood progenitor cell transplantationAnnals of Hematology, 1995
- The use of umbilical cord blood as a cellular source for correction of genetic diseases affecting the hematopoietic systemThe International Journal of Cell Cloning, 1995
- Do autologous peripheral blood cell transplants provide more than hematopoietic recovery?The International Journal of Cell Cloning, 1995
- Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion culturesBlood, 1993
- Expansion of Primitive Human Hematopoietic Progenitors in a Perfusion Bioreactor System with IL-3, IL-6, and Stem Cell FactorBio/Technology, 1993
- Mathematical descriptions of hybridoma culture kinetics: II. The relationship between thiol chemistry and the degradation of serum activityBiotechnology & Bioengineering, 1989
- Clonal growth of lymphoid cells in serum-free media requires elimination of H2O2 toxicityJournal of Cellular Physiology, 1983